Tondera Christoph, Laube Markus, Pietzsch Jens
Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
Department of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany.
Amino Acids. 2017 Jan;49(1):183-191. doi: 10.1007/s00726-016-2349-2. Epub 2016 Oct 12.
The EF-hand type calcium-binding protein S100A12 exerts numerous intra- and extracellular functions of (patho)physiological relevance. Therefore, receptors of S100A12 are of high interest for research and clinical applications. Beside the extensively studied receptor for advanced glycation endproducts (RAGE), G-protein coupled receptors and more recently, scavenger receptors are suggested to be putative S100A12 receptors. Own findings and further information from the literature predestined CD36, a class B scavenger receptor, as promising candidate. To substantiate or prove against this hypothesis, this study aimed at investigation of interaction of S100A12 and CD36 on molecular and cellular level by the use of surface plasmon resonance (SPR), radio- and fluorescence-tracer-based cell binding, and cell activation experiments. S100A12 revealed binding affinity to CD36 in the low nanomolar range, essentially, at the CD36 thrombospondin-1 binding site. Additionally, S100A12-mediated translocation of CD36 to the membrane and elevation of both CD36 and peroxisome proliferator-activated receptor γ (PPARγ) expression was observed, which suggest a potential regulatory function of S100A12-CD36 interaction.
EF 手型钙结合蛋白 S100A12 发挥着众多具有(病理)生理相关性的细胞内和细胞外功能。因此,S100A12 的受体在研究和临床应用中备受关注。除了被广泛研究的晚期糖基化终产物受体(RAGE)外,G 蛋白偶联受体以及最近被认为的清道夫受体都被推测为潜在的 S100A12 受体。我们自己的研究发现以及文献中的进一步信息表明,B 类清道夫受体 CD36 是一个有前景的候选者。为了证实或反驳这一假设,本研究旨在通过表面等离子体共振(SPR)、基于放射性和荧光示踪剂的细胞结合以及细胞激活实验,在分子和细胞水平上研究 S100A12 与 CD36 的相互作用。S100A12 在低纳摩尔范围内显示出与 CD36 的结合亲和力,基本上是在 CD36 的血小板反应蛋白 -1 结合位点。此外,观察到 S100A12 介导 CD36 向细胞膜的转位以及 CD36 和过氧化物酶体增殖物激活受体γ(PPARγ)表达的升高,这表明 S100A12 - CD36 相互作用具有潜在的调节功能。